Global Point-of-Care Glucose Market

Global Point‑of‑Care Glucose Market was valued at USD 3.79 Bn in 2025 and is expected to reach USD 4.96 Bn by 2032, growing at a CAGR of 3.9% during the forecast period.

Point-of-Care Glucose Testing Market Overview

Point-of-care testing (POCT) for glucose is used to monitor patients with diabetes at the bedside or in the home or hospital. It is typically performed by non-laboratory personnel and the results are used for clinical decision making. The implementation of point-of-care testing (POCT) is to decrease the turnaround time and improve patient care.

To Know About The Research Methodology :- Request Free Sample Report

Point-of-Care Glucose Testing Market Dynamics:

Prevalence of diabetes globally is boosting the market growth

Rising diabetes prevalence in low and middle income economies and effects associated with it like blindness, kidney failure, heart attacks and lower limb amputation, are the major factors driving the market. The global prevalence of diabetes in 2021 was 9.3% and it is estimated to rise up to 10.2% by the year 2030.The prevalence is higher in urban (10.8%) than rural (7.2%) areas, and in high-income (10.4%) than low-income countries (4.0%). According to the report published by Center for Disease Control and Prevention (CDC), the type-2 diabetes accounted for 90-95% of all the diabetes cases in US. Technological advancements which provide early, safe and accurate results are stimulating the market growth.Convenience and affordability of glucose monitoring over conventional monitoring,greater awareness and availability of glucose monitors across the globe contribute to the market growth. For instance, Accu-Chek Inform II accounted for the largest revenue share in 2018 and is anticipated to maintain this trend throughout the forecast period. Despite having these advantages, sometimes these tests offer false negative or false positive results, which may impact negatively on the market growth.

The report has profiled key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and the report has come up with recommendations for a future hot spot in the APAC region.

Point-of-Care Glucose Testing Market: Segment Analysis

In 2025, the Product Type segment shows the highest demand for Blood Glucose Monitoring Devices and Consumables. Blood Glucose Monitoring Devices remain essential for both clinical and home-based testing, offering rapid and accurate measurements. Consumables, including test strips and lancets, drive recurring demand due to continuous patient monitoring requirements. Software & Connectivity Platforms are increasingly adopted to integrate device data with electronic health records, enhancing patient management, though their overall demand is still secondary to devices and consumables.

Based on Technology, Electrochemical Glucose Sensors dominate the market in 2025 due to their accuracy, reliability, and wide adoption in both hospitals and home healthcare settings. Wearable Glucose Monitors and Non‑Invasive Glucose Monitoring technologies are emerging rapidly, driven by patient preference for minimally invasive and real-time continuous monitoring. Semi-Invasive Sensors maintain steady demand in specialized clinical applications, while Optical Glucose Sensors are gradually gaining attention, especially in research and next-generation device development.

Point-of-Care Glucose Testing Market Regional Insights

Based on Region, North America leads the Global Point-of-Care Glucose Market in 2025, driven by advanced healthcare infrastructure, high adoption of monitoring devices, and a strong focus on diabetes management programs. Europe shows steady growth, with increasing use of wearable and non-invasive glucose monitoring technologies. Asia Pacific exhibits the fastest growth, fueled by rising diabetes prevalence, expanding healthcare access, and increasing awareness of self-monitoring solutions. Other regions, including Latin America, Middle East, and Africa, show moderate demand, primarily influenced by healthcare infrastructure development and affordability of monitoring devices.

The report also helps in understanding Global Point-of-Care Glucose Testing Market dynamics, structure by analyzing the market segments and project the Global Point-of-Care Glucose Testing Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Point-of-Care Glucose Testing Market make the report investor’s guide.

Scope of the Global Point-of-Care Glucose Testing Market: Inquire before buying

Point-of-Care Glucose Testing Market, by Region:

• North America
• Europe
• South America
• MEA
• APAC

Key Players /Competitor Profiles Covered in the Global Point‑of‑Care Glucose Market Report from a Strategic Perspective

1. Abbott Laboratories
2. Roche Diagnostics
3. Medtronic
4. Dexcom
5. Johnson & Johnson
6. F. Hoffmann-La Roche AG
7. Siemens Healthineers
8. Nova Biomedical
9. Ascensia Diabetes Care
10. Bayer AG
11. Arkray Inc
12. HemoCue AB
13. LifeScan Inc
14. Nipro Corporation
15. Terumo Corporation
16. Ypsomed AG
17. EKF Diagnostics
18. Microlife AG
19. Sinocare Inc
20. GlucoMen AG
21. Ascensia Laboratories
22. Trividia Health
23. TaiDoc Technology Corporation
24. BioSense Technologies